Johnson & Johnson must pay $8B over Risperdal drug linked to male breast growth
JHVEPhoto/iStock(PHILADELPHIA) -- A Pennsylvania jury ordered Johnson & Johnson and its drugmakers Janssen Pharmaceuticals to pay $8 billion in damages in a lawsuit over the anti-psychotic drug Risperdal that has been...
